What Researchers Did
Researchers conducted a survey among EBMT centers to understand current practices and management of hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation.
What They Found
The survey had a 27% response rate, with 93% of centers having BK polyomavirus (BKPyV) diagnostic search available, and 39% performing post-transplant surveillance. Preventative measures mainly involved hyperhydration and Mesna, while primary therapeutic interventions included hyperhydration, Mesna, and analgesics. For BKPyV infection, 85% of centers used intravenous or intrabladder cidofovir.
What This Means for Canadian Patients
This survey highlights the varied approaches to managing hemorrhagic cystitis after stem cell transplantation. Canadian patients may experience different diagnostic and treatment strategies depending on their care center.
Canadian Relevance
This study does not have a direct Canadian connection as it focuses on EBMT centers, which are primarily in Europe.
Study Limitations
The survey had a relatively low response rate of 27%, which may limit the generalizability of the findings.